PCG
Private Capital Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $431K | Sell |
8,226
-9,014
| -52% | -$472K | 0.32% | 49 |
|
|
2022
Q1 | $893K | Buy |
17,240
+627
| +4% | +$32.5K | 0.2% | 68 |
|
|
2021
Q4 | $981K | Buy |
16,613
+41
| +0.2% | +$2.42K | 0.21% | 71 |
|
|
2021
Q3 | $713K | Buy |
16,572
+993
| +6% | +$42.7K | 0.16% | 91 |
|
|
2021
Q2 | $610K | Buy |
15,579
+800
| +5% | +$31.3K | 0.14% | 97 |
|
|
2021
Q1 | $535K | Sell |
14,779
-10,196
| -41% | -$369K | 0.13% | 103 |
|
|
2020
Q4 | $919K | Buy |
24,975
+1,344
| +6% | +$49.5K | 0.17% | 90 |
|
|
2020
Q3 | $867K | Sell |
23,631
-985
| -4% | -$36.1K | 0.18% | 80 |
|
|
2020
Q2 | $805K | Buy |
24,616
+870
| +4% | +$28.5K | 0.17% | 88 |
|
|
2020
Q1 | $775K | Buy |
23,746
+6,100
| +35% | +$199K | 0.2% | 78 |
|
|
2019
Q4 | $691K | Sell |
17,646
-10,628
| -38% | -$416K | 0.15% | 93 |
|
|
2019
Q3 | $1.02M | Buy |
28,274
+4,543
| +19% | +$163K | 0.18% | 87 |
|
|
2019
Q2 | $861K | Sell |
23,731
-8,844
| -27% | -$321K | 0.2% | 87 |
|
|
2019
Q1 | $1.38M | Buy |
32,575
+969
| +3% | +$41.1K | 0.26% | 62 |
|
|
2018
Q4 | $1.38M | Buy |
31,606
+4,053
| +15% | +$177K | 0.3% | 56 |
|
|
2018
Q3 | $1.21M | Buy |
27,553
+868
| +3% | +$38.2K | 0.24% | 74 |
|
|
2018
Q2 | $968K | Buy |
26,685
+1,215
| +5% | +$44.1K | 0.21% | 84 |
|
|
2018
Q1 | $904K | Buy |
25,470
+5,381
| +27% | +$191K | 0.2% | 90 |
|
|
2017
Q4 | $728 | Buy |
+20,089
| New | +$728 | 0.17% | 93 |
|